Home > Insider Trading > Filing (0001140361-13-036314)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070698	Raptor Pharmaceutical Corp	RPTP	Pharmaceutical Preparations (2834)	860883978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1243489	Erich Sager	C/O Raptor Pharmaceutical Corp. 5 Hamilton Landing, Suite 160 Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-09-16	17,000	$14.21	130,727	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock options (right to buy)	$2.57	2006-11-25	2016-05-25	174,843	174,843	Direct
Common Stock	Stock options (right to buy)	$2.57	2007-12-14	2017-06-13	17,485	17,485	Direct
Common Stock	Stock options (right to buy)	$2.02	2010-03-09	2020-03-08	13,203	13,203	Direct
Common Stock	Stock options (right to buy)	$2.97	2011-03-01	2020-10-11	30,000	30,000	Direct
Common Stock	Stock options (right to buy)	$3.54	2010-11-22	2020-11-21	90,000	90,000	Direct
Common Stock	Stock options (right to buy)	$5.13	2011-12-22	2021-09-21	30,000	30,000	Direct
Common Stock	Stock options (right to buy)	$5.13	2012-03-22	2021-09-21	90,000	90,000	Direct
Common Stock	Stock options (right to buy)	$5.49	2012-12-25	2022-09-24	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-05-25	174,843	174,843	Direct
2017-06-13	17,485	17,485	Direct
2020-03-08	13,203	13,203	Direct
2020-10-11	30,000	30,000	Direct
2020-11-21	90,000	90,000	Direct
2021-09-21	30,000	30,000	Direct
2021-09-21	90,000	90,000	Direct
2022-09-24	50,000	50,000	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
This transaction was executed in multiple trades at prices ranging from $13.95 to $14.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter.
Stock options vest 25% quarterly.
Options vest 6/36ths on the six month anniversary of grant date and 1/36th per month thereafter.
Stock options vest starting on September 1, 2010, 6/48ths on March 1, 2011 and 1/48th per month thereafter.
Stock option vests 25% immediately and 75% pro rata over 36 months.
Options vest 6/48ths immediately and 1/48th per month thereafter.
Fully vested and exercisable.
The shares listed as owned in column 9 represent the total shares for each respective option. Previous reports reflected aggregate amounts of option shares in column 9. The holding lines included on this Form 4 are included solely to correct the breakdown of shares among various stock options and are not meant to reflect any change in beneficial ownership of option shares other than those reported as a transaction on this Form 4.